Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001586226-26-000002

Interim Executive Chair sold 4,355 shares at $40.00 ($174,214)

  • Interim Executive Chair acquired 3,955 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TZIANABOS ARTHUR Interim Executive Chair 2026-03-10 Option exercise 10b5-1 +3,955 $8.33 $32,945 35,694 D
TZIANABOS ARTHUR Interim Executive Chair 2026-03-10 Sale 10b5-1 −4,355 $40.00 $174,214 31,339 D
Derivatives
TZIANABOS ARTHUR Interim Executive Chair 2026-03-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −3,955 118,696 D
Open-market sales · 4,355 sh · avg $40.00 · $174,214
Loading xslF345X05/form4-03122026_080323.xml…